These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38881151)

  • 21. Contingency management for treatment of substance abuse.
    Stitzer M; Petry N
    Annu Rev Clin Psychol; 2006; 2():411-34. PubMed ID: 17716077
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Motivation and Contingency Management Treatments for Substance Use Disorders.
    Walter KN; Petry NM
    Curr Top Behav Neurosci; 2016; 27():569-81. PubMed ID: 25762429
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contingency management: utility in the treatment of drug abuse disorders.
    Stitzer ML; Vandrey R
    Clin Pharmacol Ther; 2008 Apr; 83(4):644-7. PubMed ID: 18305456
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: a National Drug Abuse Treatment Clinical Trials Network study.
    Peirce JM; Petry NM; Stitzer ML; Blaine J; Kellogg S; Satterfield F; Schwartz M; Krasnansky J; Pencer E; Silva-Vazquez L; Kirby KC; Royer-Malvestuto C; Roll JM; Cohen A; Copersino ML; Kolodner K; Li R
    Arch Gen Psychiatry; 2006 Feb; 63(2):201-8. PubMed ID: 16461864
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adaptation of contingency management for stimulant use disorder during the COVID-19 pandemic.
    Zastepa E; Sun JC; Clune J; Mathew N
    J Subst Abuse Treat; 2020 Nov; 118():108102. PubMed ID: 32854983
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of a Multi-Target Contingency Management Intervention for HIV Positive Substance Users.
    Stitzer M; Calsyn D; Matheson T; Sorensen J; Gooden L; Metsch L
    J Subst Abuse Treat; 2017 Jan; 72():66-71. PubMed ID: 27624618
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patients' beliefs towards contingency management: Target behaviours, incentives and the remote application of these interventions.
    Getty CA; Weaver T; Lynskey M; Kirby KC; Dallery J; Metrebian N
    Drug Alcohol Rev; 2022 Jan; 41(1):96-105. PubMed ID: 34034358
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interest and preferences for contingency management design among addiction treatment clientele.
    Hartzler B; Garrett S
    Am J Drug Alcohol Abuse; 2016 May; 42(3):287-95. PubMed ID: 26646619
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Contingency management treatments.
    Petry NM
    Br J Psychiatry; 2006 Aug; 189():97-8. PubMed ID: 16880476
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contingency management and the addictions.
    Stitzer M
    Addiction; 2006 Nov; 101(11):1536-7. PubMed ID: 17034430
    [No Abstract]   [Full Text] [Related]  

  • 31. Applying behavioral activation to sustain and enhance the effects of contingency management for reducing stimulant use among individuals with HIV infection.
    Mimiaga MJ; Closson EF; Pantalone DW; Safren SA; Mitty JA
    Psychol Health Med; 2019 Mar; 24(3):374-381. PubMed ID: 30211620
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contingency management.
    Harv Ment Health Lett; 2006 Feb; 22(8):6-7. PubMed ID: 18985917
    [No Abstract]   [Full Text] [Related]  

  • 33. The urgent need for contingency management among Tribal communities in the United States: Considerations for implementation, policy, and sovereignty.
    Hirchak KA; Echo-Hawk H; Parent S; Peavy KM; Webb K; Bajet K; Richardson M; Granbois A; Herron JL; Catron K; King K; Parsells E; Freese TE; Thomas LR; Rawson R; Clark HW; Roll J; McDonell MG
    Prev Med; 2023 Nov; 176():107662. PubMed ID: 37573952
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interaction between pre-treatment drug use and heterogeneity of psychiatric diagnosis predicts outcomes in outpatients with co-occurring disorders.
    Oluwoye O; Hirchak K; Leickly E; Skalisky J; McPherson S; Srebnik D; Roll JM; Ries RK; McDonell MG
    Psychiatry Res; 2018 Feb; 260():233-235. PubMed ID: 29220679
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Virtual contingency management, what is it worth and who will pay for it?
    McKetin R; Clay S
    Addiction; 2024 Sep; 119(9):1517-1518. PubMed ID: 38752258
    [No Abstract]   [Full Text] [Related]  

  • 36. Contingency management for substance use disorders in the U.S. Veterans Health Administration: 2018-2022.
    Coughlin LN; Zhang L; Frost MC; Khazanov G; McKay JR; DePhilippis D; Lin LA
    J Subst Use Addict Treat; 2024 Aug; 163():209400. PubMed ID: 38735480
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Examining Longitudinal Stimulant Use and Treatment Attendance as Parallel Outcomes in Two Contingency Management Randomized Clinical Trials.
    McPherson S; Brooks O; Barbosa-Leiker C; Lederhos C; Lamp A; Murphy S; Layton M; Roll J
    J Subst Abuse Treat; 2016 Feb; 61():18-25. PubMed ID: 26456717
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contingency contracting with drug abusers in the natural environment.
    Boudin HM; Valentine VE; Inghram RD; Brantley JM; Ruiz MR; Smith GG; Catlin RP; Regan EJ
    Int J Addict; 1977 Feb; 12(1):1-16. PubMed ID: 863555
    [No Abstract]   [Full Text] [Related]  

  • 39. User-centered design of contingency management for implementation in opioid treatment programs: a qualitative study.
    Becker SJ; Scott K; Murphy CM; Pielech M; Moul SA; Yap KR; Garner BR
    BMC Health Serv Res; 2019 Jul; 19(1):466. PubMed ID: 31288797
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A contingency analysis of family treatment and drug abuse.
    Todd TC
    NIDA Res Monogr; 1984; 46():104-14. PubMed ID: 6427618
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.